LIGAND PHARMACEUTICALS INC
LGNDLatest QuantConomy context for LGND: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
LIGAND PHARMACEUTICALS INC
QuantConomy has a structured record for LGND. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- LGND
- Name
- LIGAND PHARMACEUTICALS INC
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq openfigi
Recent signals for LGND
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| standard proposed sale | slightly bearish | 36 | Jul 1, 09:00 PM | ANDREW REARDON filed Form 144 to sell LGND shares ($3.16M) - 10,000 shares - expected around 7/1/2026 - [weak slightly bearish signal - supply pressure] |
| material agreement | bullish | 90 | Jun 25, 09:05 PM | LGND filed 8-K: Material Definitive Agreement, Direct Financial Obligation, Unregistered Sales of Equity - 4 material events - [very strong bullish signal] |
| earnings release | neutral | 40 | Feb 26, 12:00 AM | LGND filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-26. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| LGND | NASDAQ | fmp | Ligand Pharmaceuticals Incorporated |
| LGND | NASDAQ | alpaca | Ligand Pharmaceuticals Incorporated Common Stock |
| LGND | NASDAQ | alphavantage | Ligand Pharmaceuticals Inc - Class B |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Davis Todd C | Chief Executive Officer | other | 132 | $160.71 | $21,214 | 4 on EDGAR |
| Jun 30, 2026 | Espinoza Octavio | Chief Financial Officer | other | 17 | $160.71 | $2,732 | 4 on EDGAR |
| Jun 30, 2026 | Reardon Andrew | CLO & Secretary | other | 132 | $160.71 | $21,214 | 4 on EDGAR |
| Jun 16, 2026 | Sabba Stephen L | Insider | exercise | 2,145 | $66.13 | $141,849 | 4 on EDGAR |
| Jun 12, 2026 | Haas Jason | Insider | exercise | 3,000 | $51.56 | $154,680 | 4 on EDGAR |
| Jun 5, 2026 | LAMATTINA JOHN L | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Haas Jason | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Zimmermann Martine | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Sabba Stephen L | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | KOZARICH JOHN W | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Gray Nancy Ryan | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Aryeh Jason | Insider | grant | 836 | $0.00 | $0 | 4 on EDGAR |
| Jun 1, 2026 | Reardon Andrew | CLO & Secretary | exercise | 5,000 | $52.27 | $261,350 | 4 on EDGAR |
| May 27, 2026 | Espinoza Octavio | Chief Financial Officer | exercise | 764 | $63.62 | $48,606 | 4 on EDGAR |
| May 1, 2026 | KOZARICH JOHN W | Insider | sale | 80 | $227.37 | $18,189 | 4 on EDGAR |
| May 1, 2026 | Reardon Andrew | CLO & Secretary | exercise | 5,000 | $52.27 | $261,350 | 4 on EDGAR |
| Apr 1, 2026 | Reardon Andrew | CLO & Secretary | exercise | 5,000 | $52.27 | $261,350 | 4 on EDGAR |
| Apr 1, 2026 | KOZARICH JOHN W | Insider | sale | 146 | $199.97 | $29,196 | 4 on EDGAR |
| Mar 23, 2026 | Sabba Stephen L | Insider | sale | 1,000 | $207.87 | $207,873 | 4 on EDGAR |
| Mar 11, 2026 | Espinoza Octavio | Chief Financial Officer | exercise | 2,405 | $92.65 | $222,823 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query LGND context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access